Juliane W.
- Country
- Germany
- Department
- Exzellenzcluster iFIT (EXC 2180) Peptid-basierte Immuntherapie KKE Translationale Immunologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the treatment of acute myeloid leukemia (AML), with particular emphasis on cases involving measurable residual disease (MRD). Their research activities center on developing innovative therapeutic approaches for hematologic malignancies.
- Acute Myeloid Leukemia Management
- Residual Disease Monitoring
- Novel Therapeutic Applications
Through their clinical investigations, they focus on advancing treatment options for patients with persistent disease markers following initial therapy.
Precision Medicine
The investigator's work encompasses targeted therapeutic approaches in hematologic malignancies, with specific attention to molecular monitoring and disease progression assessment.
- Targeted Therapy Development
- Disease Monitoring Strategies
- Treatment Response Assessment
Their research interests include the evaluation of novel compounds for treating resistant or persistent leukemia.
Clinical Development
The investigator's expertise extends to early-phase clinical development of therapeutic agents for hematologic disorders, focusing on innovative treatment approaches for challenging disease states.
- Early-Phase Clinical Studies
- Treatment Innovation
- Patient Response Evaluation
Their work involves investigating new therapeutic options for patients with specific disease markers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.